SCHEMBL614536

SCHEMBL614536

CCN1CCSC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24001174 0.84
SCHEMBL327702 0.82
SCHEMBL15483896 0.80 POLB (0.45)
SCHEMBL806009 0.79
SCHEMBL11340023 0.77 GAA (0.36)
SCHEMBL11357218 0.77 GAA (0.36)
SCHEMBL19088932 0.76
SCHEMBL15187046 0.75
SCHEMBL17540482 0.74
SCHEMBL1920038 0.74 GNAI3 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103172182-B Scale-inhibition and dispersion synergist applied to high-temperature and high-pH value circulating water and preparation method thereof CENTRAL RES INST BUILDING & CO 2014-04-16 CN claimed
CN-103172182-A Scale-inhibition and dispersion synergist applied to high-temperature and high-pH value circulating water and preparation method thereof CENTRAL RES INST BUILDING & CO 2013-06-26 CN claimed
US-20230322816-A1 PYRAZOLE BORONIC ACID COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USES THEREOF BEIJING SONGRUN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-10-12 US disclosed
US-20230265055-A1 STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS OXFORD FINANCE LLC 2023-08-24 US disclosed
CN-114514936-B Application of thiazole thioketone in preparation of bird repellent 宁波三江益农化学有限公司 2023-08-18 CN disclosed
US-11008596-B2 Cytochrome P450 BM3 enzyme variants for preparation of cyclopropanes CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2021-05-18 US disclosed
EP-2298761-B1 HIV INHIBITING PYRIMIDINES DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2020-03-25 EP disclosed
US-20190211367-A1 VIVO AND IN VITRO OLEFIN CYCLOPROPANATION CATALYZED BY HEME ENZYMES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2019-07-11 US disclosed
WO-2017200984-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. (US) 2017-11-23 WO disclosed
US-20170320835-A1 HIV REPLICATION INHIBITING PYRIMIDINES JANSSEN PHARMACEUTICA NV (BE) 2017-11-09 US disclosed
US-20170247725-A1 IN VIVO AND IN VITRO OLEFIN CYCLOPROPANATION CATALYZED BY HEME ENZYMES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2017-08-31 US disclosed
US-20060135764-A1 Indazole-carboxamide compounds THERAVANCE, INC. 2006-06-22 US disclosed
EP-0780730-B1 Positive-type light-sensitive lithographic printing plate FUJI PHOTO FILM CO LTD (JP) 2002-08-21 EP disclosed
EP-0780730-A2 Positive-type light-sensitive lithographic printing plate FUJI PHOTO FILM CO., LTD. (JP) 1997-06-25 EP disclosed
EP-0501693-B1 Isoquinoline derivatives BANYU PHARMA CO LTD (JP) 1996-08-28 EP disclosed
US-5362736-A Alkoxy derivatives for cardiovascular disorders BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-11-08 US disclosed
EP-0501693-A1 Isoquinoline derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1992-09-02 EP disclosed
EP-0054748-B1 PROCESS FOR THE PREPARATION OF AQUEOUS SOLUTIONS OF CATIONIC ORGANOSILICIUM COMPOUNDS Degussa Aktiengesellschaft (DE) 1984-09-26 EP disclosed
US-4390712-A Aqueous solution of cationic organosilicon compounds and process for the production of the solutions DEGUSSA AG (DE) 1983-06-28 US disclosed
EP-0054748-A2 Process for the preparation of aqueous solutions of cationic organosilicium compounds Degussa Aktiengesellschaft (DE) 1982-06-30 EP disclosed